fda glp-1 compounding enforcement news Report: must enforce rules on compounded GLP-1s FDA is moving to restrict
Description
Possible concerns for people with heart conditions include: Gastrointestinal side effects like nausea, vomiting, or diarrhea may affect nutrition and hydration
2019;21(Suppl 1):72-81
The immediate priority is to address the drug delivery challenge
"What happens after stopping an obesity medication is exactly what happens after stopping a diabetes, cholesterol-lowering, or a blood pressure medication," he told ABC News
doi:10.1155/2018/1205121
GLP-1 is a naturally occurring incretin hormone released by the intestines in response to food intake
